Monday, April 27, 2026
HomeTagsDay One Biopharmaceuticals

Day One Biopharmaceuticals

Servier Strengthens Oncology Portfolio with Day One Biopharmaceuticals Acquisition

Servier has announced the completion of its acquisition of Day One Biopharmaceuticals, which is valued at roughly $2.5 billion. It represents a key milestone...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics